What is Sunrise?
Sunrise operates as a healthtech company headquartered in Belgium, specializing in the development and provision of a comprehensive platform for sleep apnea testing and management. The company aims to streamline the diagnostic process and enhance patient care for individuals affected by this prevalent sleep disorder, leveraging technology to improve accessibility and efficacy of treatment.
How much funding has Sunrise raised?
Sunrise has raised a total of $3.7M across 1 funding round:
Other Financing Round
$3.7M
Other Financing Round (2021): $3.7M with participation from Kurma Partners
Key Investors in Sunrise
Kurma Partners
Kurma Partners is a European venture capital firm with a strong focus on healthcare and biotechnology, investing from early-stage to growth capital. They are known for supporting innovative projects from research institutions and young companies in Biotech and MedTech.
What's next for Sunrise?
The recent major strategic investment signals a new phase of growth and development for Sunrise. This capital infusion is expected to fuel further innovation in their sleep apnea platform, potentially expanding market reach and enhancing technological capabilities. The enterprise-level funding suggests a focus on scaling operations and solidifying its position as a leader in the healthtech sector for sleep disorder management.
See full Sunrise company page
